Propel Bio Management, LLC
- SEC CIK
- 0001969764
- Latest filing
- Aug 13, 2026
Holdings in Q2 2025
Holdings as of Jun 30, 2025, filed Aug 13, 2025. Long positions only; changes compare share counts with Q1 2025.
- Positions
- 16
- −2 vs. Q1 2025
- Portfolio value
- $82.4M
- −$3.68M (−4.3%) vs. Q1 2025
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| PAGPPlains GP Holdings LP | LTD PARTNR INT A | 1,272,360 | $24.7M | 30.0% | 00.0% | Unchanged | History |
| ACHVAchieve Life Sciences, Inc. | COM | 6,153,091 | $13.9M | 16.9% | +3,699,999+150.8% | Added | History |
| AKROAkero Therapeutics, Inc. | COM | 228,884 | $12.2M | 14.8% | 00.0% | Unchanged | History |
| PHATPhathom Pharmaceuticals, Inc. | COM | 922,927 | $8.85M | 10.7% | −212,000−18.7% | Reduced | History |
| ABEOAbeona Therapeutics Inc. | COM NEW | 974,022 | $5.53M | 6.7% | +350,000+56.1% | Added | History |
| APLTApplied Therapeutics, Inc. | COM | 11,285,420 | $3.51M | 4.3% | 00.0% | Unchanged | History |
| MISTMilestone Pharmaceuticals Inc. | COM | 1,791,557 | $3.48M | 4.2% | +340,000+23.4% | Added | History |
| DCTHDelcath Systems, Inc. | COM NEW | 226,052 | $3.07M | 3.7% | +48,452+27.3% | Added | History |
| TCRXTScan Therapeutics, Inc. | COM | 2,087,139 | $3.03M | 3.7% | 00.0% | Unchanged | History |
| ZVRAZevra Therapeutics, Inc. | COM NEW | 231,874 | $2.04M | 2.5% | +52,000+28.9% | Added | History |
| CAPRCapricor Therapeutics, Inc. | COM NEW | 70,000 | $695.1K | 0.8% | +70,000 | New | History |
| Maat Pharma SacaF5888J116 | COMM | 94,181 | $452.1K | 0.5% | −72,242−43.4% | Reduced | – |
| LONALeonaBio, Inc. | COM | 1,492,792 | $450.8K | 0.5% | 00.0% | Unchanged | History |
| EIGREiger BioPharmaceuticals, Inc. | COM NEW | 146,381 | $423.0K | 0.5% | 00.0% | Unchanged | History |
| WTS - Achieve Life Sci004468187 | COMM | 3,699,999 | $13.7K | <0.1% | +3,699,999 | New | – |
| Contra Chinook Therapeu169CVR016 | COM | 79,357 | $2.50K | <0.1% | 00.0% | Unchanged | – |
Sold out since Q1 2025 (4)
Positions held at the end of Q1 2025 that are gone from this filing.
| Security | Class | Shares in Q1 2025 | Value in Q1 2025 | % of portfolio in Q1 2025 | History |
|---|---|---|---|---|---|
| MDGLMadrigal Pharmaceuticals, Inc. | COM | 30,032 | $9.95M | 11.6% | History |
| Avidity Biosciences, Inc.05370A108 | COM | 178,500 | $5.27M | 6.1% | – |
| SNDXSyndax Pharmaceuticals Inc | COM | 183,259 | $2.25M | 2.6% | History |
| CMPXCompass Therapeutics, Inc. | COM | 228,317 | $433.8K | 0.5% | History |